Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dorothee
Dorothee Debavelaere-Callens, Sameon FR
| Patent application number | Description | Published |
|---|---|---|
| 20110314920 | DEVICE AND METHOD FOR STUDYING A STUDY AREA BY MEANS OF AN ACOUSTIC WAVE - A device includes a substrate | 12-29-2011 |
Dorothee Foernzler, Lenzburg CH
| Patent application number | Description | Published |
|---|---|---|
| 20100092947 | Impdh2 snp associated with acute rejection - The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a polymorphism in intron 7 of the IMPDH2 gene, optionally in combination with polymorphisms of the MDR1 and IL 10 genes which were found to be associated with this disease. | 04-15-2010 |
| 20110182892 | Methods to identify responsive patients - The present invention provides methods and kits for improving the progression-free survival of a patient suffering from gastrointestinal cancer and for assessing the sensitivity or responsiveness of the patient to treatment comprising bevacizumab. | 07-28-2011 |
Dorothee Foernzler, Lenzburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20090286234 | IL10 SNP ASSOCIATED WITH ACUTE REJECTION - The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a poly-morphism in the promoter region of the IL 10 gene, optionally in combination with polymorphisms of the MDR1 and IMPDH2 genes which were found to be associated with this disease. | 11-19-2009 |
| 20090286235 | Mdr1 Snp in Acute Rejection - The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a polymorphism in exon 26 of the MDR1 gene, optionally in combination with polymorphisms of the IMPDH2 and IL 10 genes which were found to be associated with this disease. | 11-19-2009 |
Dorothee Gierschner, Teningen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090041789 | Monoclonal Antibodies and Single Chain Antibody Fragments Against Cell-Surface Prostate Specific Membrane Antigen - Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody. | 02-12-2009 |
Dorothee Heidemeter, Dusseldorf DE
| Patent application number | Description | Published |
|---|---|---|
| 20080220034 | Antiadhesive Polymers for Prevention of Adhesion of Microorganisms to Textiles and for Prevention of Laundry Odor - Textile treatment agents and/or capsules comprising a polymer having antiadhesive action against microorganisms which adhere to a textile substrate, methods of treating textile substrates therewith and the textile so treated, wherein the polymer comprises a polymeric structural element selected from the group consisting of polyesters, polysaccharides, polyethers, polyurethanes, polyureas, polyamides, and heteropolymers thereof. | 09-11-2008 |
Dorothee Kloepping, Schlangen DE
| Patent application number | Description | Published |
|---|---|---|
| 20120064202 | METHOD AND DEVICE FOR PRODUCING PUREED FOOD - A method, device, and knife system for producing purëed, cooked foodstuffs from piece-form raw material. The method includes pre-chopping of the piece-form raw material in a pre-chopping unit, cooking of the pre-chopped raw material in a cooking plant, and final processing of the cooked product in a final-processing unit. Before cooking, the piece-form raw material is cut into small pieces by the pre-chopping unit such that a pumpable mass is produced from the piece-form raw material. | 03-15-2012 |
Dorothee Lang, Pinneberg DE
| Patent application number | Description | Published |
|---|---|---|
| 20090139519 | OXYGEN SUPPLY SYSTEM FOR GENERATING OXYGEN FROM CABIN AIR IN AN AIRCRAFT - An oxygen supply system is provided for generating oxygen from cabin air in an aircraft. The oxygen supply system exhibits a modular cabin unit with an oxygen port and a decentralized oxygen supply unit with an oxygen outlet, and the decentralized oxygen supply unit is set up in the modular cabin unit. The decentralized oxygen supply unit is set up to generate oxygen-enriched air from the cabin air by means of electrical power, and the oxygen-enriched air can be provided to the oxygen port of the modular cabin unit via the oxygen outlet. | 06-04-2009 |
Dorothee Le Garrec, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20090130183 | Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol - The invention relates to a bilayer composition for the delivery of acetaminophen and tramadol over at least a twelve hour period following initial administration. A single administration of the bilayer composition can provide analgesia starting in less than half an hour to about one hour after initial administration with a duration of at least twelve hours after initial administration. | 05-21-2009 |
| 20090258071 | COMPOSITIONS AND METHODS FOR PH TARGETED DRUG DELIVERY - The invention provides compositions and methods for the targeted, in particular, pH targeted, delivery of pharmaceutically active agents in mammals. The compositions comprise pH sensitive diblock copolymers, which permit the release of the pharmaceutically active agent when exposed to an environment having a particular pH. The compositions are particularly useful for the oral delivery of water insoluble pharmaceutically active agents. | 10-15-2009 |
Dorothee Maroserro, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090299212 | System and Method for Analyzing Progress of Labor and Preterm Labor - Systems and methods for monitoring uterus contraction activity and progress of labor. The system of the subject invention can comprises (1) a plurality of sensors; (2) an amplifying/filtering means; (3) a computing means; and (4) a graphical user interface. Accurate clinical data, which can be extracted and provided to the user in real-time using the system of the invention, include without limitation, progress of labor, prediction and monitoring of preterm labor, and intrauterine pressure prediction. In a preferred embodiment, the system of the invention includes an intelligence means, such as a neural network system, to analyze and interpret clinical data for use in clinical diagnosis as well as delivery strategy. | 12-03-2009 |
Dorothee Marossero, Coogee AU
| Patent application number | Description | Published |
|---|---|---|
| 20120071744 | Sensor Interface System - A sensor interface system for providing a connection between at least one sensor and a maternal-fetal monitor, wherein the interface system converts electrical muscle activity captured by the sensor(s) into uterine activity data signals for use by the maternal-fetal monitor. The sensor interface system of the invention preferably includes a conversion means for converting the signals from the sensor(s) into signals similar to those produced by a tocodynamometer. | 03-22-2012 |
Dorothee Marossero, Gainesville, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110112440 | Electrode Interface System - An electrode interface system for providing a connection between at least one electrode and a maternal-fetal monitor, wherein the interface system converts electrical muscle activity captured by the electrode(s) into uterine activity data signals for use by the maternal-fetal monitor. The electrode interface system of the invention preferably includes a conversion means for converting the signals from the electrode(s) into signals similar to those produced by a tocodynometer. | 05-12-2011 |
| 20110192398 | OBSTETRIC ANALGESIA SYSTEM - The present invention relates to systems and methods for providing a short-acting analgesic agent in the management of pain during labor, wherein the system enables efficient, real-time prediction of contractions for the coordinated administration of analgesia such that the peak effectiveness of the analgesic coincides with the intermittent pain of labor. | 08-11-2011 |
Dorothee Martin, Suresnes FR
| Patent application number | Description | Published |
|---|---|---|
| 20080269039 | Method of Refining Glass and Product Obtained - The subject of the invention is a method of refining glass for which the temperature (T log 2) corresponding to a viscosity of 100 poise (10 Pa·s) is greater than or equal to 1480° C., characterized in that sulfides are used as a refining agent. It also relates to the glass article capable of being obtained by this method. | 10-30-2008 |
| 20100069219 | METHOD OF REFINING A LITHIUM ALUMINOSILICATE GLASS AND GLASS-CERAMIC OBTAINED - The present invention relates to a method of refining lithium aluminosilicate glass capable of being controllably ceramized and free of arsenic oxide, antimony oxide and tin oxide, in which at least 0.05% by weight of at least one sulfide is added to the glass batch materials and said materials are melted at a temperature below 1750° C. | 03-18-2010 |
Dorothee Misse, Montpellier FR
| Patent application number | Description | Published |
|---|---|---|
| 20090062375 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES - The invention provides a method of treating viral haemorrhagic fevers, such as that caused by Dengue virus, which comprises administering a composition comprising a pharmaceutically active amount of a matrix metalloproteinase inhibitor. | 03-05-2009 |
Dorothee Sommer, Stuttgart DE
| Patent application number | Description | Published |
|---|---|---|
| 20100012096 | FUEL INJECTION DEVICE FOR AN INTERNAL COMBUSTION ENGINE - The fuel injection device for an internal combustion engine comprises a feed pump which has an electric drive, by which feed pump fuel is fed from a fuel storage tank into a low-pressure region to the suction side of at least one high-pressure pump. The high-pressure pump pumps fuel into a high-pressure region in which at least one injector is provided to inject the fuel into the internal combustion engine. The fuel injection is controlled by an electric control device. Arranged in the low-pressure region is a pressure sensor which is connected to the control device. The electric drive of the feed pump is activated by the control device in order to set a feed quantity of the feed pump which is variable as a function of at least one operating parameter of the internal combustion engine and/or of the high-pressure pump. The drive of the feed pump is in particular activated by the control device in such a way that, at a high load of the internal combustion engine and/or at a high rotational speed and/or at a high fuel temperature, a greater fuel quantity is fed by the feed pump into the low-pressure region than at a low load and/or a low rotational speed and/or a low fuel temperature. | 01-21-2010 |
| 20100307459 | METHOD AND DEVICE FOR CONTROLLING A FUEL-SUPPLY SYSTEM - In a method for controlling a fuel-supply system, a first supply unit supplies fuel from a storage container to a second supply unit. At least a partial quantity of the fuel quantity supplied by the first supply unit returns to the storage container as return quantity via a return line. The return quantity is determined as a function of the operating state of the fuel-supply system. The first supply unit is controlled at least as a function of the return quantity. | 12-09-2010 |
Dorothee Viemann, Muenster DE
| Patent application number | Description | Published |
|---|---|---|
| 20110166059 | MEANS AND METHODS FOR EVALUATING A THERAPY WITH A P38 MAP KINASE INHIBITOR - The present invention relates to a method for determining whether therapy with a p38 MAP kinase inhibitor is potentially beneficial or potentially contraindicated for a subject suffering from a p38-mediated condition comprising measuring in a sample obtained from the subject the presence of at least one chromatin remodelling gene and/or of at least one pro-inflammatory gene, wherein the treatment is potentially beneficial for the subject, if at least one chromatin remodelling gene is underrepresented and/or at least one pro-inflammatory gene is overrepresented in comparison to a reference sample obtained from a subject not suffering from a p38-mediated condition; or wherein the treatment is potentially contraindicated for the subject, if at least one chromatin remodelling gene is overrepresented and/or at least one pro-inflammatory gene is underrepresented in comparison to a reference sample obtained from a subject not suffering from a p38-mediated condition. The present invention also relates to medical uses and methods of treatment applying a p38 MAP kinase inhibitor for treating a p38-mediated condition in a subject, wherein the patient is amenable to the treatment with the p38 MAP kinase inhibitor, if in the subject at least one chromatin remodelling gene is underrepresented and/or at least one pro-inflammatory gene is overrepresented in comparison to a reference sample obtained from a subject not suffering from a p38-mediated condition. Furthermore, a packaged medicament and a kit are provided comprising a p38 MAP kinase inhibitor or means for determining the presence of at least one chromatin remodelling gene and/or at least one pro-inflammatory gene in a sample from a subject suffering from a p38-mediated condition and instructions for use indicating that a subject suffering from a p38-mediated condition is amenable to the treatment with the p38 MAP kinase inhibitor, if it has been determined whether in said subject at least one chromatin remodelling gene is underrepresented and/or at least one pro-inflammatory gene is overrepresented in comparison to a reference sample obtained from a subject not suffering from a p38-mediated condition. | 07-07-2011 |